IBEX Ltd’s Chief People Officer, Inson Paul Joseph, reported equity compensation activity. On February 6, 2026, he acquired 25,180 IBEX common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
One-third of the award vested on February 6, 2026, with additional one‑third tranches scheduled for February 6, 2027 and February 6, 2028, subject to continued service. On the same date, 2,627 shares were sold at $34.98 to cover taxes upon vesting, leaving him with 27,469 common shares held directly.
IBEX Limited reports strong growth in its quarter ended December 31, 2025, with revenue of $164.2 million, up 16.7% from a year earlier, driven by HealthTech, Retail & E-commerce, Travel, Transportation & Logistics, and digital marketing.
Quarterly net income rose 31.8% to $12.2 million, and diluted EPS increased to $0.83. For the six-month period, revenue grew 16.6% to $315.4 million and net income rose 44.4% to $24.3 million, reflecting margin gains from higher mix in offshore delivery centers.
Operating cash flow reached $22.3 million in the first half versus $8.9 million a year earlier, while debt remained low at $1.4 million and IBEX had $67.3 million available under its revolving credit facilities. The company continued buybacks, repurchasing 169,858 shares for $5.6 million, and highlights ongoing AI-enabled CX solutions and tax holidays that reduce its effective tax rate.
IBEX Limited filed a current report to share that it has released financial results for its second fiscal quarter ended December 31, 2025. On February 5, 2026, the company issued a press release detailing these quarterly results, which is included as Exhibit 99.1. The report notes that this earnings information is being furnished rather than filed, meaning it is not automatically incorporated into other securities law filings unless specifically referenced.
IBEX Ltd’s Chief AI & Digital Officer has updated her reported shareholdings. The officer now reports direct beneficial ownership of 6,696 common shares. This amended filing corrects the prior holdings disclosure and explains how past equity awards and related tax share sales affect the total.
The explanation notes a November 8, 2024 grant of 3,521 restricted stock units, with 25% vesting on July 1, 2025 and annually thereafter. When the July 1, 2025 portion vested, 315 shares were sold for tax purposes, leaving 565 fully vested shares from this grant.
The filing also describes 490 fully vested performance stock units and a separate grant of 3,000 restricted stock units that vest 25% on September 16, 2026 and annually thereafter. Overall, the document primarily clarifies the structure and status of this executive’s equity-based compensation and current direct share ownership.
IBEX Ltd filed an initial ownership report for Chief AI & Digital Officer Michael Joseph Darwal. As of January 1, 2026, he beneficially owned 7,011 common shares. This amount includes 490 fully vested shares, 3,521 restricted stock units granted on November 18, 2024 that vest 25% on July 1, 2025 and annually thereafter, and 3,000 restricted stock units granted on September 16, 2025 that vest 25% on September 16, 2026 and annually thereafter. All holdings are reported as directly owned.
Ibex Limited (IBEX) reported that its Board of Directors has created a formal Nominating Committee made up entirely of independent directors. Previously, nominating duties were handled by the independent members of the full Board, a structure that the company notes already complied with Nasdaq rules requiring that director nominations be made solely by independent directors.
The new Nominating Committee will identify and evaluate director candidates, recommend nominees each year, and set criteria for board and committee membership, as outlined in its charter on the company’s website. The Board appointed Daniella Ballou-Aares as Chair, along with Karen Batungbacal, Fiona Beck, Patrick McGinnis, and Mingzhe (JJ) Zhuang, each determined to be independent under Nasdaq and SEC standards.
Upon formation, the Committee ratified prior actions of the independent directors and re-nominated the existing slate of director candidates for election at the annual meeting scheduled for December 5, 2025. These steps were taken in response to concerns raised by proxy advisory firms Institutional Shareholder Services and Glass Lewis about the nominating process, and the company believes the changes fully resolve those issues.
IBEX Ltd reported an amended insider transaction. The company’s Chief Executive Officer and Director filed a Form 4/A to record the exercise of a stock option for 45,027 common shares at $19 on 09/16/2025 (transaction code M). The filing shows 0 derivative securities remaining afterward, indicating this option position was fully exercised.
The amendment explains that the acquisition and sale of the shares underlying this option were previously reported on September 17, 2025, and the option exercise itself was inadvertently omitted and is now included. The option was fully vested and exercisable, with an expiration date of 08/07/2030. Ownership is listed as Direct.
IBEX Ltd reported an insider equity award. The company’s Chief Technology Officer filed a Form 4 for a grant of 15,000 Restricted Stock Units (RSUs) on November 11, 2025. Each RSU converts into one common share. The filing lists the acquisition at $0 and shows 15,000 shares beneficially owned directly after the transaction.
The RSUs vest over four years: 3,750 units on November 11, 2026, with an additional 3,750 units vesting annually thereafter, subject to continued service.
IBEX Limited reported strong quarterly results for the period ended September 30, 2025. Revenue reached $151.2 million, up 16.5% year over year, as growth from Retail & E‑commerce, HealthTech, Travel, and Other verticals offset declines in Telecommunications. Net income rose to $12.0 million, with diluted EPS of $0.82.
Profitability improved with operating margin at 9.1% and adjusted EBITDA of $19.5 million (12.9% margin), reflecting mix shift to higher‑margin offshore delivery and disciplined SG&A. Cash from operating activities was $15.7 million, driving free cash flow of $8.0 million. Liquidity remained solid with cash of $22.7 million, total debt of $1.6 million, and net cash of $21.1 million, plus $67.4 million available under HSBC credit facilities.
The company repurchased 91,658 shares for $2.7 million and had $10.6 million remaining under its 2025 buyback authorization. Shares outstanding were 13,467,175 as of October 31, 2025.
IBEX Limited filed a current report to let investors know it has released its financial results for the first fiscal quarter ended September 30, 2025. On November 6, 2025, the company issued a press release covering these quarterly results, which is included as Exhibit 99.1 to the report. The company notes that this information is being furnished, not filed, meaning it is not subject to certain liability provisions of the securities laws or automatically incorporated into other SEC filings.